In CD30-positive cutaneous lymphoproliferations (LyP and cALCL), we recently identified highly recurrent genetic alterations within the JAK/STAT pathway (SNVs and fusions) as the molecular driving force of CD30-positive LPD [20]. This evidence concerns the gene TNFRSF8 and disseminated peritoneal leiomyomatosis.